Morgan Stanley’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-13,086
| Closed | -$1.55M | – | 8009 |
|
|
2021
Q1 | $1.55M | Sell |
13,086
-2,870
| -18% | -$339K | ﹤0.01% | 4452 |
|
|
2020
Q4 | $1.89M | Buy |
15,956
+13,336
| +509% | +$1.55M | ﹤0.01% | 4214 |
|
|
2020
Q3 | $291K | Sell |
2,620
-157
| -6% | -$16.9K | ﹤0.01% | 4914 |
|
|
2020
Q2 | $283K | Sell |
2,777
-3,030
| -52% | -$324K | ﹤0.01% | 4903 |
|
|
2020
Q1 | $626K | Buy |
5,807
+2,219
| +62% | +$255K | ﹤0.01% | 4252 |
|
|
2019
Q4 | $417K | Sell |
3,588
-3,813
| -52% | -$442K | ﹤0.01% | 5034 |
|
|
2019
Q3 | $848K | Buy |
7,401
+3,872
| +110% | +$385K | ﹤0.01% | 4394 |
|
|
2019
Q2 | $336K | Sell |
3,529
-2,373
| -40% | -$223K | ﹤0.01% | 4799 |
|
|
2019
Q1 | $539K | Buy |
5,902
+2,303
| +64% | +$188K | ﹤0.01% | 4502 |
|
|
2018
Q4 | $273K | Sell |
3,599
-1,590
| -31% | -$117K | ﹤0.01% | 5151 |
|
|
2018
Q3 | $415K | Sell |
5,189
-5,905
| -53% | -$550K | ﹤0.01% | 5101 |
|
|
2018
Q2 | $1.1M | Sell |
11,094
-104,706
| -90% | -$9.05M | ﹤0.01% | 4565 |
|
|
2018
Q1 | $9.38M | Sell |
115,800
-78,121
| -40% | -$6.31M | ﹤0.01% | 2399 |
|
|
2017
Q4 | $15.3M | Buy |
193,921
+94,183
| +94% | +$7.83M | ﹤0.01% | 1949 |
|
|
2017
Q3 | $9.2M | Buy |
99,738
+55,761
| +127% | +$5.36M | ﹤0.01% | 2366 |
|
|
2017
Q2 | $4.97M | Sell |
43,977
-80,644
| -65% | -$9.01M | ﹤0.01% | 2855 |
|
|
2017
Q1 | $12.5M | Buy |
124,621
+76,229
| +158% | +$8.15M | ﹤0.01% | 1990 |
|
|
2016
Q4 | $5.2M | Buy |
48,392
+11,908
| +33% | +$1.39M | ﹤0.01% | 2944 |
|
|
2016
Q3 | $4.54M | Sell |
36,484
-114,378
| -76% | -$13.5M | ﹤0.01% | 2746 |
|
|
2016
Q2 | $16M | Buy |
150,862
+100,173
| +198% | +$11.6M | 0.01% | 1596 |
|
|
2016
Q1 | $5.8M | Sell |
50,689
-6,773
| -12% | -$795K | ﹤0.01% | 2388 |
|
|
2015
Q4 | $8.19M | Sell |
57,462
-88,354
| -61% | -$10.2M | ﹤0.01% | 2180 |
|
|
2015
Q3 | $13.1M | Sell |
145,816
-16,742
| -10% | -$1.77M | ﹤0.01% | 1720 |
|
|
2015
Q2 | $18.7M | Buy |
162,558
+11,626
| +8% | +$1.22M | 0.01% | 1550 |
|
|
2015
Q1 | $14.4M | Sell |
150,932
-32,543
| -18% | -$2.43M | 0.01% | 1723 |
|
|
2014
Q4 | $12.3M | Buy |
183,475
+59,111
| +48% | +$3.66M | ﹤0.01% | 1877 |
|
|
2014
Q3 | $6.71M | Sell |
124,364
-79,109
| -39% | -$3.89M | ﹤0.01% | 2377 |
|
|
2014
Q2 | $9.05M | Buy |
203,473
+172,787
| +563% | +$7.06M | ﹤0.01% | 2125 |
|
|
2014
Q1 | $1.07M | Sell |
30,686
-247
| -0.8% | -$7.87K | ﹤0.01% | 3942 |
|
|
2013
Q4 | $892K | Buy |
30,933
+22,096
| +250% | +$641K | ﹤0.01% | 4012 |
|
|
2013
Q3 | $258K | Sell |
8,837
-14,011
| -61% | -$349K | ﹤0.01% | 4737 |
|
|
2013
Q2 | $530K | Buy |
+22,848
| New | +$577K | ﹤0.01% | 4214 |
|
Morgan Stanley's CBPO Position: Q2 2021 in Review
Morgan Stanley sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 13,086 shares — an estimated $1.55M sold.
Morgan Stanley first reported a position in CBPO in Q2 2013 and held it in 32 quarters. The position peaked at $18.7M in Q2 2015. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.
- Morgan Stanley reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
- Morgan Stanley sold 13,086 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $1.55M.
- Morgan Stanley first reported a position in China Biologic Products Holdings, Inc. in Q2 2013 and held it in 32 quarters.
- Morgan Stanley's China Biologic Products Holdings, Inc. position peaked at $18.7M in Q2 2015.
- 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.
Based on Morgan Stanley's 13F filing for Q2 2021, filed 16 Aug 2021.